Literature DB >> 23698661

Perceptions of predisposing, enabling, and reinforcing factors influencing the use of a continuity of care document in special needs PLWH.

Michelle Odlum1, Peter Gordon, Eli Camhi, Rebecca Schnall, Paul Teixeira, Suzanne Bakken.   

Abstract

The provision of personal health information through electronic personal health management tools (EPHMT) has the potential to improve health outcomes. However, little is known about factors that affect EPHMT use in special needs people living with HIV/AIDS (PLWH). The purpose of this study was to describe PLWH perceptions of predisposing, enabling, and reinforcing factors affecting use of one type of EPHMT, a continuity of care document (CCD). Data were collected through focus groups and qualitative interviews with PLWH (n=35), health care providers (N=19) and care site managers (N=5). All participant types identified predisposing barriers to CCD use including literacy, privacy, and technology access and enabling factors to promote CCD use including user support and password simplicity. People living with HIV/AIDS also identified reinforcing factors for recurring CCD use including emergent situations and reducing test redundancy. Results inform methods to promote use of the CCD and other EPHMT by special needs PLWH.

Entities:  

Mesh:

Year:  2012        PMID: 23698661     DOI: 10.1353/hpu.2012.0172

Source DB:  PubMed          Journal:  J Health Care Poor Underserved        ISSN: 1049-2089


  2 in total

Review 1.  Enroling and retaining human immunodeficiency virus (HIV) patients in their care: A metasynthesis of qualitative studies.

Authors:  Dalmacio Flores; Natalie Leblanc; Julie Barroso
Journal:  Int J Nurs Stud       Date:  2016-07-25       Impact factor: 5.837

2.  Processes and outcomes of developing a continuity of care document for use as a personal health record by people living with HIV/AIDS in New York City.

Authors:  Peter Gordon; Eli Camhi; Ron Hesse; Michelle Odlum; Rebecca Schnall; Martha Rodriguez; Esmerlin Valdez; Suzanne Bakken
Journal:  Int J Med Inform       Date:  2012-07-26       Impact factor: 4.046

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.